.png){kind=icon}
.png){kind=icon}
Return
Exploratory analysis of HER2-positive/CLDN18.2-positive metastatic gastric and gastroesophageal junction cancer toward future therapeutic development
.png){kind=icon}
PRE
AI
O
N
S
DOI：10.1016/j.esmogo.2026.100315.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
Journal
E
IF:
0
Papers:
65
Citations:
0
Organization
Cited Papers